The Glaucoma Therapeutics Market Is Witnessing Robust Growth in North America

 Glaucoma is a group of eye conditions that damage the optic nerve, the health of which is vital for good vision. Optic nerve disorder is a rare autoimmune disease that indicates degeneration of the optic nerve. An individual with glaucoma can use eye drops, take oral medications, or undergo eye surgery such as laser therapy. Glaucoma therapeutics help to reduce intraocular pressure by decreasing aqueous humor production or improving aqueous outflow, or a combination of both. The glaucoma therapeutics market is expected to witness robust growth due to increasing prevalence of the disease and the growing geriatric population.

 

Glaucoma is a leading cause of irreversible blindness in the United States and the world. According to BrightFocus Foundation, formerly known as the American Health Assistance Foundation, in 2020, around 80 million people had glaucoma worldwide, and this number is expected to increase to over 111 million by 2040. Moreover, glaucoma is one of the leading causes of blindness for people over the age of 60. According to the World Health Organization (WHO), by 2050, the world's population aged 60 years and older is expected to total 2 billion, up from 900 million in 2015. Thus, with increasing prevalence of glaucoma, the demand for glaucoma therapeutics is also increasing.

For instance, in March 2019, Aerie Pharmaceuticals received approval from the Food and Drug Administration (FDA) to begin selling Rocklatan, a once-daily eye drop for reducing high intraocular pressure in patients with open-angle glaucoma or ocular hypertension. Open-angle glaucoma is the most common form and affects approximately 95% of individuals. It is three to four times more common in African Americans than in non-Hispanic Whites. The most common types of glaucoma are primary open angle and primary angle closure glaucoma. Thus, the glaucoma therapeutics market is gaining huge traction due to the increasing prevalence and increasing demand for glaucoma therapeutics.

Moreover, growth of the glaucoma therapeutics market is driven by the increasing prevalence of diabetes as people with diabetic retinopathy have an increased risk of glaucoma. Glaucoma may occur among the people with or without diabetes. According to National Eye Institute, the number of Americans with diabetic retinopathy is expected to nearly double, from 7.7 million to 14.6 million from 2010 to 2050. However, drug recalls by market players could have a predominant impact on the glaucoma therapeutics market. For instance, in October 2017, Allergan had to recall seven lots of Combigan and one lot of Lumigan due to testing results not meeting the regulatory specifications for individual and total impurities.

Increasing prevalence of nose bleeding to accelerate the growth of the epistaxis market

 

Epistaxis, also known as Perleche, occurs when a small amount of blood in the nasal cavities (the mucous membrane that protects the sensitive membranes of the nose) forms a crust on the back of the tongue, which blocks the tip of the nose and causes a nosebleed. Epistaxis can cause bleeding or nosebleeds, especially if there is not enough blood flow through the blocked area, which inflates and deflates to provide immediate nosebleed relief. The most affected areas are the soft palate (the area behind the front teeth), the ethmoid region of the nose, and the conjunctiva.

North America is expected to dominate the global epistaxis market in the near future and this is accredited to the high prevalence of hypertension in the region. According to the U.S. Department of Health & Human Services, Nearly half of adults in the United States (108 million, or 45%) have hypertension defined as a systolic blood pressure ≥ 130 mm Hg or a diastolic blood pressure ≥ of 80 mm Hg or are taking medication for hypertension. Hypertension is one of the major causes of nose bleeding.

The increasing prevalence of nose bleeding due to dry climate and lack of humidity in the atmosphere is significantly propelling the growth of the epistaxis market. According to the National Center for Biotechnology Information, about 60% of people have experienced a nosebleed during their life, and only 10% of nosebleeds are severe enough to warrant treatment/medical intervention. They occur most commonly in children ranging from 2 to 10 years old and the elderly ranging from 50 to 80 years old. Moreover, the growing incidence of the heart-related disorder is leading to hypertension which is also one of the causes of nose bleeding, thereby propelling the growth of the epistaxis market. According to the World Health Organization, an estimated 1.13 billion people worldwide have hypertension, most (two-thirds) living in low- and middle-income countries.

Key Developments:

1. In September 2017, Optinose, an ENT / Allergy specialty pharmaceutical company, announced that the U.S. Food & Drug Administration (FDA) approved the Company’s New Drug Application (NDA) for XHANCE (previously referred to by the development name OPN-375) for the treatment of nasal polyps in patients 18 years of age and older

2. In June 2019, The U.S. Food and Drug Administration approved Dupixent (dupilumab) to treat adults with nasal polyps (growths on the inner lining of the sinuses) accompanied by chronic rhinosinusitis

The Discrete Capacitors Market Is Gaining Rapid Traction Due To the Rapid Growth of the Electronics Industry

 

Discrete capacitors have become an indispensable part of various electronic devices and are used extensively in their manufacturing. Discrete capacitors find indispensable applications in almost all industries that use any form of electronics or electrical manufacturing. Thus, growth of the discrete capacitors market is primarily driven by the increasing demand for electronics, which include consumer appliances & devices, computing, telecommunications, and industrial electronics, as well as increasing adoption of discrete capacitors across different sectors to meet the increasing demand for energy-efficient devices. Modern appliances such as dishwashers, clothes washers, dryers, ovens, freezers, etc. use significantly less energy than older appliances.

In December 2019, Toshiba launched the GT20N135SRA, a 1350V discrete IGBT for use in voltage resonance circuits in tabletop IH cookers, IH rice cookers, microwave ovens, and other home appliances. Moreover, in 2019, Energy Efficiency Services Ltd. (EESL), India launched its Super-Efficient Air Conditioning Programme for residential and institutional consumers. Moreover, India has committed to reducing its energy intensity (units of energy use per unit of GDP) by 33 to 35% by 2030. The implementation of various energy efficiency schemes by the Bureau of Energy Efficiency, such as Energy Conservation Building Code (ECBE), Demand Side Management (DSM), National Mission for Enhanced Energy Efficiency (NMEEE), etc. have yielded positive results.

Moreover, the growing trend of miniaturization in the consumer electronics is expected to boost the demand for discrete capacitor, which in turn, is expected to drive the discrete capacitors market growth. Discrete capacitors also find applications across various end-user segments, such as consumer electronics, healthcare, automotive, and information & telecommunication, among others. For instance, in December 2020, Vishay Intertechnology, Inc. launched a new series of low impedance, Automotive Grade miniature aluminium electrolytic capacitors, while in September 2020, the company introduced a series of Automotive Grade DC-Link metallized polypropylene film capacitors optimized for high humidity environments.

The healthcare and automotive sectors are also expected to exhibit moderate growth owing to the increasing awareness about safety, rapid advancements in both healthcare and automotive sectors, and their use of highly efficient equipment. Furthermore, proliferation of connected devices, such as wearables and smartphones, have provided significant impetus for the growth of the discrete capacitors market. Moreover, advancements, such as advent of supercapacitors, compact sizes, and increased charge capacity, have potential to replace li-ion batteries, which in turn, are expected to provide significant momentum to the discrete capacitors market growth.

With the increasing demand for Internet of Thing (IoT), the demand for discrete capacitors is also expected to increase in the next few years. The increasing popularity of IoT devices along with the increased use of capacitors and sensors has increased the use of discrete capacitors.

The Global Diabetes Vaccine Market Is Witnessing Constant Demand Coming From Healthcare Sectors Owing To the Prevalence of the Disease Worldwide

Diabetes vaccine studies have been underway for several years but progress is slow in translating these results into successful treatments for humans. There are several different types of diabetes vaccines on the market today, but none are available for use by people with Type I or Type II diabetes. However, there is one diabetes vaccine that is being evaluated in the United States and that may become a potential treatment for people with Type I and/or II diabetes. The diabetes vaccine holds great promise for treating both juvenile and chronic blood sugar-related conditions. While the vaccine is currently being tested in healthy adults, it has shown promising results in animals with non-diabetic conditions such as liver disease and pancreatic cancer.

 

Diabetes has become one of the most prevalent chronic diseases across the globe. For instance, according to World Health Organization, around 422 million individuals across the globe, have diabetes. The majority of the diagnosed cases have been found in low and middle-income nations and recently 1.6 million deaths are directly linked to the diseases annually. Owing to all these factors, there has been significant demand in the global diabetes vaccine market. Moreover, patients who are diagnosed with type 1 diabetes require constant monitoring and may also need external insulin shots, which they have to take intramuscularly daily. This especially becomes tough for children, which is augmenting the growth of the global diabetes vaccine market.

Based on early clinical trials in non-diabetic animals, the diabetes vaccine combines a pharmaceutical drug called C-peptide, a protein complex attached to an enzyme called GABA (primary inhibitor of insulin), and an antioxidant called superoxide dismutase (SOD). To date, much of the diabetes vaccine development has been conducted on laboratory animals, with very limited human testing being performed. However, the cost of the diabetes vaccines is the main restraining factor hindering the growth of the global diabetes vaccine market.

The prevalence of diabetes in North America is very high, there is a constant demand in the global diabetes vaccine market. For instance, according to the U.S. Centers for Disease Control and Prevention, around 34.2 million U.S. residents have been diagnosed with diabetes in 2020 and around 88 million adults have pre-diabetes. Moreover, the awareness among individuals related to diabetes control and health is also fueling the existing demand of the diabetes vaccine market. The favorable health policies and government support, the demand in the diabetes vaccine market in the Asia Pacific are also increasing constantly. Owing to all these factors, there have been some significant industrial developments in the global diabetes vaccine market. For instance, in 2018, Imcys announced the continuation of its clinical trials for developing new vaccines to treat type 1 diabetes.

In-depth Report on Global Diabetes Vaccine Market by Coherent Market Insights:

https://www.coherentmarketinsights.com/ongoing-insight/diabetes-vaccine-market-1367

The Global Cutting Equipment Market Continues To Grow Owing To the Rising Demand from Manufacturing and Other End-Use Industries

Cutting equipment is a category of tools used for various metal cutting processes. These include gas flame cutting, electric cutters, gas torch, electrical, angle grinder, and the diamond blade. The cutting blades are used to cut through metals of all kinds such as iron, aluminum, steel, bronze, titanium, copper, zinc, and nickel. The gas torch is one of the most important pieces of cutting equipment used in the welding process. In this process, an arc is created between an electrode and the workpiece. The workpiece and the electrode are placed in a chamber with a slight difference in pressure that causes the electrode to become an arc. A cutting tool is used to create the arc, which is a direct contact between the workpiece and the electrode. A welding helmet is worn by the welder during the welding process to protect the eyes from sparks that may fly out due to the arc's intensity.

 

End-use industries such as aerospace, automotive, and others across the have created the main demand for cutting equipment in the global cutting equipment market. Hence the expansion of these sectors is also expanding the demand across the global market. For instance, according to the Society of Indian Automobile Manufacturers (SIAM), as of May 2020, 13 out of 29 states of the region had automotive manufacturing plants. The technologies related to Oxy-fuel cutting are extensively used because of features such as precision cuts, relatively low cost, and high speed.

All this is fueling the demand in the global cutting equipment market. Moreover, owing to such increasing demand, advanced cutting technologies are also evolving and key companies are investing more in R&D activities to earn advantages in terms of product capabilities, product pricing, and manufacturing efficiency. These factors are in turn augmenting the demand in the global cutting equipment market. However, the cost of the equipment is the main factor that has proximity to hinder the growth of the global cutting equipment market.

Owing to the presence of large numbers of manufacturing plants, where usage of cutting machines is substantial, Asia Pacific is witnessing a constant growth in the global cutting equipment market. For instance, according to the China Association of Automobile Manufacturers (CAAM), in 2018, the total automotive production of the country reached around 27.8 million units, which was way far ahead of the other major markets such as the United States with 11.3 million units and Japan with 9.7 million units. Moreover, economies in the Asia Pacific region have low operating costs that attract various businesses from bigger manufacturing bases, which is also aiding the growth of the global cutting equipment market. North America is known for its rapid technological advancements in all sectors including equipment, devices, and services, which is benefiting the growth of the global cutting equipment market.

In-depth Report on Global Cutting Equipment Market by Coherent Market Insights:

https://www.coherentmarketinsights.com/market-insight/cutting-equipment-market-1037

Clinical data management market is gaining major traction with Inspirata Inc. launching AI-enabled cloud-based cancer and clinical data extraction software service

 Clinical data management is an important procedure in clinical studies, which results in the generation of reliable, high-quality, and generally meaningful data from medical trials. Data management thus aims at improving the quality of the results of clinical researches through the collection, analysis, and sharing of data. It is useful for various research purposes, including pre-clinical and clinical studies, drug development, and regulatory activities. Many pharmaceutical and biotechnology companies have taken significant advantage of clinical data management since these organizations are focused on R&D activities and investing frequently. Recently, in January 2021, AstraZeneca invested US$ 520 million in France across the spectrum of manufacturing and R&D. Such investments have increased the adoption of clinical data management to gain high-quality and reliable insights as well as sound data from clinical trials. Thus, these factors can augment growth of the clinical data management market.

Clinical data management requires robust infrastructure with advanced facilities and many government hospitals as well as private hospitals do not have the same. Such adversities can hinder the adoption of clinical data management solutions. Besides, low internet penetration in emerging economies can restrict growth of the clinical data management market in the near future. 

 

An effective clinical data management system should meet the specific needs of the involved clinical trial. Ideally, a well-designed clinical data management system should include all the data collection elements that have an influence on the quality of the outcomes of the clinical trial. Developed regions especially North America seemed to have gained rapid traction in the clinical data management market in the recent past. This is due to the fact that there high adoption of advanced technology, which is complemented with robust healthcare infrastructure. Emerging economies such as India and China are exhibiting promising signs for the adoption of clinical data management solutions as there is a presence of major government incentives.

A good clinical data management system should provide the necessary infrastructure and services needed by researchers and investigators. It should allow for easily tracking and accessing clinical trial details and other information from clinical trial participants. In the recent past, personalized patient care has gained significant traction across the globe. Although it is an overarching framework for care, it typically means providing coordinated care with the primary objective of promoting health and preventing disease. The demand for personalized medicine has also increased over the years since they offer improved disease detection and avoid predictable side-effects. Hence, such factors can stimulate growth of the clinical data management market in the near future.

Recently, in March 2020, Inspirata Inc. introduced cloud-based cancer and clinical data extraction software service, leveraging the power of artificial intelligence (AI) and natural language processing (NLP).

Calcium Chloride Powder Anhydrous Market to witness robust growth Occidental Chemical Corporation completing the acquisition of Anadarko Petroleum Corporation for US$ 55 billion

 Calcium chloride is commonly used in the manufacture of plastic, rubber, and other thermally insulating materials. It can be used as an additive or a component in a wide variety of chemical formulations. It can be added to antifreeze, diesel, gasoline, synthetic oil, paint, varnish, polyurethane, lubricants, sealants, pesticides, and many other products. While these products do not require high temperatures to add or remove, they do need to be stored in an environment free of moisture and extreme temperatures. The textile industry has register a robust demand for calcium chloride power in the recent past. It is typically used as a sizing agent as well as in refrigeration plants for the preparation of brine solution. Over the years, the textile industry has emerged as one of the most promising sectors in terms of value and volume, in both developed and emerging economies. As per the India Brand Equity Foundation (IBEF), the Indian textiles and apparel market was valued at US$ 100 billion in 2019, employing around 45 million workers across the country. Hence, such factors can augment growth of the calcium chloride powder anhydrous market.

 

With respect to geographical footprint, Asia Pacific has witnessed high demand for chloride powder anhydrous over the years. This is due to the fact that there has been a steady growth in the chemicals sector. Furthermore, North America is registering high adoption of chloride powder anhydrous. Rapid growth of the pharmaceutical sector can boost the regional chloride powder anhydrous market growth in the near future.

Recently, in May 2019, Occidental Chemical Corporation, a U.S.-based provider of calcium chloride products, acquired Anadarko Petroleum Corporation for US$ 55 billion.

Calcium chloride powder is one of the most common anhydrous calcium formulations used in various industries. It can be found in a number of common powders, such as Epsom salt, Magnesium sulfate, and Rock Salt. This powdery compound is highly versatile and can be used for a variety of applications. Similarly, other end-use industries such as chemicals, pharmaceuticals, and dyestuff have also exhibited high adoption of anhydrous calcium chloride powder. In medicines, this powder is mainly used as electrolyte replacement as well as an anti-allergic agent. Hence, such advantageous factors can stimulate growth of the calcium chloride powder anhydrous market in the near future.

Despite the fact that there is a massive demand for anhydrous calcium chloride powder, its storage requires specific conditions since it can absorb moisture from the air and convert it into liquid brine. Thus, specialty containers are required to maintain product quality during the storage period. Hence, such adversities can limit growth of the calcium chloride powder anhydrous market.